Determine phenotypical patterns of resistance to antibiotics in COVID-19 patients with associated bacterial infection: largest medical center in Iran.

IF 1.3 Q4 MICROBIOLOGY
Esmaeil Mohammadnejad, Arash Seifi, Reza Ghanei Gheshlagh, Amir Aliramezani, Samrand Fattah Ghazi, Mohammadreza Salehi, Seyed Ali Dehghan Manshadi, Amirhossein Orandi
{"title":"Determine phenotypical patterns of resistance to antibiotics in COVID-19 patients with associated bacterial infection: largest medical center in Iran.","authors":"Esmaeil Mohammadnejad,&nbsp;Arash Seifi,&nbsp;Reza Ghanei Gheshlagh,&nbsp;Amir Aliramezani,&nbsp;Samrand Fattah Ghazi,&nbsp;Mohammadreza Salehi,&nbsp;Seyed Ali Dehghan Manshadi,&nbsp;Amirhossein Orandi","doi":"10.18502/ijm.v15i3.12893","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Antibacterial resistance (AMR) is a serious threat and major concern, especially in developing countries. Therefore, we aimed to determine phenotypical patterns of resistance to antibiotics in COVID-19 patients with associated bacterial infection in intensive care units.</p><p><strong>Materials and methods: </strong>In this cross-sectional study, 6524 COVID-19 patients admitted for more than 48 h in the ICUs of Imam Khomeini Complex Hospital (IKCH) in Tehran from March 2020 to January 2022 were included in the study with initial diagnosis of COVID-19 (PCR test and chest imaging). Data were collected regarding severity of the illness, primary reason for ICU admission, presence of risk factors, presence of infection, length of ICU and hospital stay, microbial type, and antibiotic resistance. In this study, the pattern of antibiotic resistance was determined using the Kirby-Bauer disk diffusion method.</p><p><strong>Results: </strong>In this study, 439 (37.5%) were ventilator-related events (VAEs), and 46% of all hospitalized patients had an underlying disease. The most common microorganisms in COVID-19 patients were carbapenem resistant <i>Klebsiella pneumoniae</i> (KPCs) (31.6%), <i>Escherichia coli</i> (<i>E. coli</i>) (15.8%), and <i>Acinetobacter baumannii</i> (<i>A. baumannii</i>) (15.7%), respectively. Prevalence of vancomycin-resistant enterococci (VRE) and KPCs were 88% and 82%, respectively.</p><p><strong>Conclusion: </strong>A study on AMR surveillance is the need of the hour as it will help centers to generate local antibiograms that will further help formulate national data. It will guide doctors to choose the appropriate empiric treatment, and these studies will be the basis for establishing antimicrobial surveillance and monitoring and regulating of the use of antimicrobials.</p>","PeriodicalId":14633,"journal":{"name":"Iranian Journal of Microbiology","volume":"15 3","pages":"336-342"},"PeriodicalIF":1.3000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/af/23/IJM-15-336.PMC10336291.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/ijm.v15i3.12893","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objectives: Antibacterial resistance (AMR) is a serious threat and major concern, especially in developing countries. Therefore, we aimed to determine phenotypical patterns of resistance to antibiotics in COVID-19 patients with associated bacterial infection in intensive care units.

Materials and methods: In this cross-sectional study, 6524 COVID-19 patients admitted for more than 48 h in the ICUs of Imam Khomeini Complex Hospital (IKCH) in Tehran from March 2020 to January 2022 were included in the study with initial diagnosis of COVID-19 (PCR test and chest imaging). Data were collected regarding severity of the illness, primary reason for ICU admission, presence of risk factors, presence of infection, length of ICU and hospital stay, microbial type, and antibiotic resistance. In this study, the pattern of antibiotic resistance was determined using the Kirby-Bauer disk diffusion method.

Results: In this study, 439 (37.5%) were ventilator-related events (VAEs), and 46% of all hospitalized patients had an underlying disease. The most common microorganisms in COVID-19 patients were carbapenem resistant Klebsiella pneumoniae (KPCs) (31.6%), Escherichia coli (E. coli) (15.8%), and Acinetobacter baumannii (A. baumannii) (15.7%), respectively. Prevalence of vancomycin-resistant enterococci (VRE) and KPCs were 88% and 82%, respectively.

Conclusion: A study on AMR surveillance is the need of the hour as it will help centers to generate local antibiograms that will further help formulate national data. It will guide doctors to choose the appropriate empiric treatment, and these studies will be the basis for establishing antimicrobial surveillance and monitoring and regulating of the use of antimicrobials.

确定伴有相关细菌感染的COVID-19患者抗生素耐药性的表型模式:伊朗最大的医疗中心
背景和目的:抗菌药物耐药性(AMR)是一个严重的威胁和主要问题,特别是在发展中国家。因此,我们的目的是确定重症监护病房中伴有相关细菌感染的COVID-19患者抗生素耐药的表型模式。材料与方法:本横断面研究将2020年3月至2022年1月在德黑兰伊玛目霍梅尼综合医院(IKCH)重症监护室住院48小时以上的6524例COVID-19患者纳入研究,初步诊断为COVID-19 (PCR检测和胸部影像学)。收集有关疾病严重程度、进入ICU的主要原因、存在危险因素、存在感染、ICU和住院时间、微生物类型和抗生素耐药性的数据。本研究采用Kirby-Bauer圆盘扩散法测定抗生素耐药模式。结果:在本研究中,439例(37.5%)为呼吸机相关事件(VAEs), 46%的住院患者有基础疾病。COVID-19患者中最常见的微生物分别为耐碳青霉烯类肺炎克雷伯菌(KPCs)(31.6%)、大肠杆菌(E. coli)(15.8%)和鲍曼不动杆菌(A. baumannii)(15.7%)。万古霉素耐药肠球菌(VRE)和KPCs患病率分别为88%和82%。结论:AMR监测研究是当务之急,因为它将帮助各中心生成当地抗生素图,从而进一步帮助制定国家数据。它将指导医生选择适当的经验性治疗,这些研究将成为建立抗微生物药物监测以及监测和规范抗微生物药物使用的基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.40
自引率
7.10%
发文量
96
审稿时长
12 weeks
期刊介绍: The Iranian Journal of Microbiology (IJM) is an international, multi-disciplinary, peer-reviewed journal that provides rapid publication of the most advanced scientific research in the areas of basic and applied research on bacteria and other micro-organisms, including bacteria, viruses, yeasts, fungi, microalgae, and protozoa concerning the development of tools for diagnosis and disease control, epidemiology, antimicrobial agents, clinical microbiology, immunology, Genetics, Genomics and Molecular Biology. Contributions may be in the form of original research papers, review articles, short communications, case reports, technical reports, and letters to the Editor. Research findings must be novel and the original data must be available for review by the Editors, if necessary. Studies that are preliminary, of weak originality or merely descriptive as well as negative results are not appropriate for the journal. Papers considered for publication must be unpublished work (except in an abstract form) that is not under consideration for publication anywhere else, and all co-authors should have agreed to the submission. Manuscripts should be written in English.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信